LISSA MCCLENDON: Open Payments
NPI 1194425298 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,414 in 47 payments from 13 companies in 2025. Trend: 2023 $1,043 · 2024 $959 · 2025 $1,414
Food & beverage: $1,339Education: $75
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $279 |
| Daiichi Sankyo Inc. | 7 | $229 |
| Eisai Inc. | 9 | $189 |
| Integra LifeSciences Corporation | 1 | $175 |
| Merck Sharp & Dohme LLC | 8 | $162 |
| Genmab U.S., Inc. | 3 | $89 |
| SEAGEN INC. | 1 | $75 |
| Spectrum Pharmaceuticals Inc. | 4 | $73 |
| ABBVIE INC. | 3 | $72 |
| Ethicon US, LLC | 1 | $21 |
Products named: LYNPARZA, Enhertu, Lenvima, CODMAN CERTAS, KEYTRUDA, Tivdak, ROLVEDON, ELAHERE.
Industry payments across TX — which companies pay providers there.
